24th May 2006 18:15
GlaxoSmithKline PLC24 May 2006 GlaxoSmithKline plc Executive Directors' details Further to the announcement dated 6 February 2006, the following details for DrMonsif Slaoui are provided in accordance with the requirements of the FinancialServices Authority's Listing Rules on his appointment to the Board ofGlaxoSmithKline plc with effect from 17 May 2006. Dr Slaoui has not been a director of a publicly quoted company during the pastfive years. Dr Slaoui has interests in 38,820 Ordinary Shares of GlaxoSmithKline plc. Allof these interests in Ordinary Shares were acquired prior to Dr Slaoui taking uphis appointment to the Board of GlaxoSmithKline plc. Dr Slaoui also has aninterest directly and indirectly via his spouse in 134,500 Ordinary Sharesarising from the grant of options under the Company's share option schemes,5,860 Ordinary Shares under the Company's Share Value Plan and 59,163 OrdinaryShares under the Company's Performance Share Plan, all of which were grantedprior to his taking up his appointment as a director. Paragraph 9.6.13 R (2) to (6) Financial Services Authority's Listing Rules Dr Slaoui has no details to disclose in respect of paragraph 9.6.13 R (2) to (6)of the Financial Services Authority's Listing Rules. S M BicknellCompany Secretary 24 May 2006 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline